BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23569906)

  • 1. Syzygium cumini (L.) Skeels: a review of its phytochemical constituents and traditional uses.
    Ayyanar M; Subash-Babu P
    Asian Pac J Trop Biomed; 2012 Mar; 2(3):240-6. PubMed ID: 23569906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syzygium cumini (L.) Skeels., a novel therapeutic agent for diabetes: folk medicinal and pharmacological evidences.
    Ayyanar M; Subash-Babu P; Ignacimuthu S
    Complement Ther Med; 2013 Jun; 21(3):232-43. PubMed ID: 23642956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syzygium cumini(L.),Skeels fruit extracts: In vitro and in vivo anti-inflammatory properties.
    Qamar M; Akhtar S; Ismail T; Yuan Y; Ahmad N; Tawab A; Ismail A; Barnard RT; Cooper MA; Blaskovich MAT; Ziora ZM
    J Ethnopharmacol; 2021 May; 271():113805. PubMed ID: 33465442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of crude hydroalcoholic extract of Syzygium cumini (L.) Skeels leaves and continuous aerobic training in rats with diabetes induced by a high-fat diet and low doses of streptozotocin.
    Baldissera G; Sperotto ND; Rosa HT; Henn JG; Peres VF; Moura DJ; Roehrs R; Denardin EL; Dal Lago P; Nunes RB; Saffi J
    J Ethnopharmacol; 2016 Dec; 194():1012-1021. PubMed ID: 27794509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic and anti-diabetic potential, metabolic profiling and
    Eldin Elhawary SS; Elmotyam AKE; Alsayed DK; Zahran EM; Fouad MA; Sleem AA; Elimam H; Rashed MH; Hayallah AM; Mohammed AF; Abdelmohsen UR
    Nat Prod Res; 2022 Feb; 36(4):1026-1030. PubMed ID: 33146032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syzygium cumini (L.) Skeels extracts; in vivo anti-nociceptive, anti-inflammatory, acute and subacute toxicity assessment.
    Qamar M; Akhtar S; Ismail T; Wahid M; Ali S; Nazir Y; Murtaza S; Abbas MW; Ziora ZM
    J Ethnopharmacol; 2022 Apr; 287():114919. PubMed ID: 34995693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syzygium cumini (L.) SKEELS (Myrtaceae) against diabetes--125 years of research.
    Helmstädter A
    Pharmazie; 2008 Feb; 63(2):91-101. PubMed ID: 18380393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Chemical and Biological Potential of Jamun (Syzygium cumini (L.) Skeels) Leaves: A Comprehensive Review.
    Kumari N; Kumar M; Chaudhary N; Zhang B; Radha ; Chandran D; Joshi S; Singh D; Dey A; Rajalingam S; Natarajan K; Muthukumar M; Mohankumar P; Sheri V; Dhumal S; Lorenzo JM
    Chem Biodivers; 2023 Sep; 20(9):e202300479. PubMed ID: 37667613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant action and enzyme activity modulation by bioaccessible polyphenols from jambolan (Syzygium cumini (L.) Skeels).
    Sousa MM; Lima RMT; Lima A; Reis AC; Cavalcante AACM; Sattler JAG; Almeida-Muradian LB; Lima Neto JS; Moreira-Araujo RSDR; Nogueira NDN
    Food Chem; 2021 Nov; 363():130353. PubMed ID: 34147898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase and protein tyrosine phosphatase 1B inhibitory active compounds from Syzygium cumini seeds.
    Sawant L; Singh VK; Dethe S; Bhaskar A; Balachandran J; Mundkinajeddu D; Agarwal A
    Pharm Biol; 2015 Aug; 53(8):1176-82. PubMed ID: 25853967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientific validation of the antidiabetic effects of Syzygium jambolanum DC (black plum), a traditional medicinal plant of India.
    Baliga MS; Fernandes S; Thilakchand KR; D'souza P; Rao S
    J Altern Complement Med; 2013 Mar; 19(3):191-7. PubMed ID: 23030429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic effects of Syzygium cumini leaves: A non-hemolytic plant with potential against process of oxidation, glycation, inflammation and digestive enzymes catalysis.
    Franco RR; Ribeiro Zabisky LF; Pires de Lima Júnior J; Mota Alves VH; Justino AB; Saraiva AL; Goulart LR; Espindola FS
    J Ethnopharmacol; 2020 Oct; 261():113132. PubMed ID: 32673709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in polyphenolics during maturation of Java plum (Syzygium cumini Lam.).
    Lestario LN; Howard LR; Brownmiller C; Stebbins NB; Liyanage R; Lay JO
    Food Res Int; 2017 Oct; 100(Pt 3):385-391. PubMed ID: 28964361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacognostical standardization and antidiabetic activity of Syzygium cumini (Linn.) barks (Myrtaceae) on streptozotocin-induced diabetic rats.
    Tripathi AK; Kohli S
    J Complement Integr Med; 2014 Jun; 11(2):71-81. PubMed ID: 24760764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive activity of Syzygium cumini leaves ethanol extract on orofacial nociception protocols in rodents.
    Quintans JS; Brito RG; Aquino PG; França PH; Siqueira-Lima PS; Santana AE; Ribeiro EA; Salvador MJ; Araújo-Júnior JX; Quintans-Júnior LJ
    Pharm Biol; 2014 Jun; 52(6):762-6. PubMed ID: 24559393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of Different Solvents in the Extraction of Bioactive Compounds from
    Correia VTDV; Silva VDM; Mendonça HOP; Ramos ALCC; Silva MR; Augusti R; de Paula ACCFF; Ferreira RMSB; Melo JOF; Fante CA
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syzygium cumini (L.) skeels: a prominent source of bioactive molecules against cardiometabolic diseases.
    Chagas VT; França LM; Malik S; Paes AM
    Front Pharmacol; 2015; 6():259. PubMed ID: 26578965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactive compounds and pharmacological and food applications of Syzygium cumini - a review.
    Chhikara N; Kaur R; Jaglan S; Sharma P; Gat Y; Panghal A
    Food Funct; 2018 Dec; 9(12):6096-6115. PubMed ID: 30379170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of folk medicines in the management of type 2 diabetes mellitus: results of a randomized controlled trial of Syzygium cumini (L.) Skeels.
    Teixeira CC; Fuchs FD; Weinert LS; Esteves J
    J Clin Pharm Ther; 2006 Feb; 31(1):1-5. PubMed ID: 16476114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle formulation increases Syzygium cumini antioxidant activity in Candida albicans-infected diabetic rats.
    Bitencourt PE; Cargnelutti LO; Stein CS; Lautenchleger R; Ferreira LM; Sangoi M; Denardi L; Borges RM; Boligon A; Moresco RN; Cruz L; Zanette RA; Alves SH; Moretto MB
    Pharm Biol; 2017 Dec; 55(1):1082-1088. PubMed ID: 28193098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.